Paper I
2023 July (Supplementary) (2019 Scheme) · 100 marks · 180 min

Question

What is the rationale of using Beta-blockers in Glaucoma.

Q114 marksShort Answers

Answer

Aqueous humour is continuously formed by the ciliary epithelium through a beta-adrenergic-receptor-driven, cAMP-mediated secretory process. Topical beta-blockers (Timolol, Betaxolol) block these beta receptors on the ciliary epithelium, reducing cAMP-mediated aqueous humour production and thereby lowering intraocular pressure — this is a production-reducing mechanism, distinct from prostaglandin analogues’ outflow-increasing mechanism, and does not rely on any effect on pupil size or accommodation (unlike older miotic agents). Given topically, systemic absorption is low but not negligible, so beta-blockers still carry systemic contraindications (bronchial asthma, heart block, bradycardia) despite the local route of administration.

Other Years Asked


Revise MBBS
Preview